18.1 C
New York
Wednesday, June 3, 2026

Tag: cannabinoids

MediPharm Labs Positioned for Unique Opportunities on Possible Rescheduling of Cannabis in the United States

MediPharm Labs holds unique US Food and Drug Administration (FDA) site registration in relation to the manufacturing and release of pharmaceutical cannabis products.  MediPharm...

Revive Therapeutics Announces Closing of First Tranche of Private Placement and Debt Settlement

TORONTO, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company dedicated to developing innovative therapeutics for critical medical needs, announces that it has closed the first tranche of its previously announced private placement offering (the “Offering”). The first tranche of the Offering consisted of the issuance of 2,900,000 units of the Company (each, a “Unit”), at a price of $0.021 per Unit, for total gross proceeds to Revive of $60,900. Furthermore, the Company announces that it has settled an amount of $67,400 owing pursuant to an arm’s length note through the issuance of 3,209,523 Units, at a price of $0.021 per Unit, being the same issue price and security offered pursuant to the Offering.

THC Gummies Launch in 2025: Delta-9, Sleep, and CBD Hybrid Editions

Exhale Wellness introduces new THC gummies in 2025, including Delta-9, Sleep, and CBD hybrid options for flavor, balance, and targeted cannabinoid support.
 Exhale Wellness introduces new THC gummies in 2025, including Delta-9, Sleep, and CBD hybrid options for flavor, balance, and targeted cannabinoid support.

Exhale Wellness Recognized as the #1 Delta 9 THC Gummies by Onpattison

Exhale Wellness earns top spot for best Delta 9 gummies in 2025, recognized for quality, transparency, and customer satisfaction by Onpattison.
Exhale Wellness earns top spot for best Delta 9 gummies in 2025, recognized for quality, transparency, and customer satisfaction by Onpattison.

Revive Therapeutics Announces Proposed Private Placement and Debt Settlement

TORONTO, July 30, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company dedicated to developing innovative therapeutics for critical medical needs, announces that it is proposing to arrange a private placement offering of up to 30,952,381 units, at a price of $0.021 per unit, for gross proceeds to Revive of up to $650,000, and to settle $67,400 owing pursuant to an arm’s length note payable by the issuance of 3,209,523 units, at a price of $0.021 per unit, being the same issue price and security being offering pursuant to the private placement.

Elevate Holistics Launches Comprehensive Cannabis E-Book After Years of Consulting Patients on the Most Important Questions When It Comes to Cannabis

MORGANTOWN, W.Va., July 28, 2025 /PRNewswire/ -- "Everything You've Ever Wanted to Know About Cannabis, Finally Written Down" ...

Valley Hemp Introduces THCa Flower Wholesale Guide for 2025 Hemp Market Growth

The THCa Valley does not stop at the provision of high-quality hemp.

ExhaleWell Recognized as #1 Best Delta 9 Gummies by San Diego Magazine

Check out the reasons why ExhaleWell has been recognized as the best brand for Delta 9 Gummies by San Diego Magazine.
Check out the reasons why ExhaleWell has been recognized as the best brand for Delta 9 Gummies by San Diego Magazine. 

Avicanna Announces Closing of Non-Brokered Private Placement

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS

Disposable Weed Pen: Premium Award-Winning All-in-One THC Vaporizers Launched by Area 52

Area 52 launches its new line of Disposable Weed Pens – backed by a 90-day 100% money back satisfaction guarantee.
Area 52 launches its new line of Disposable Weed Pens – backed by a 90-day 100% money back satisfaction guarantee.

Exhale Wellness Ranked No.1 THCA Flower Brand in 2025

Exhale Wellnes was recently ranked No.1 THCA flower brand by industry peers. Read more about its product line, bestsellers, and why it stood out.
Exhale Wellnes was recently ranked No.1 THCA flower brand by industry peers. Read more about its product line, bestsellers, and why it stood out. 

Revive Therapeutics Clarifies Completion of Key Nerve Agent Countermeasure Study

TORONTO, July 08, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialized life sciences company dedicated to the research and development of therapeutics for infectious diseases and medical countermeasures, hereby clarifies its update regarding the research study assessing Bucillamine as a potential treatment for nerve agent exposure. This study is being conducted in collaboration with Defence R&D Canada – Suffield Research Centre (“DRDC”), an agency of the Canadian Department of National Defence, which is investigating pharmacological compounds, including Bucillamine, capable of mitigating nerve agent-induced brain injury.

Delta 9 Gummies: Exhale Launches New Bottle Caps Delta 9 Gummies (2025 Collection)

Exhale Wellness launches its new line of Delta 9 Gummies - Bottle Caps. Learn about the product - ingredients, flavors, lab tests, etc. Read User Reviews
Exhale Wellness launches its new line of Delta 9 Gummies - Bottle Caps. Learn about the product - ingredients, flavors, lab tests, etc. Read User Reviews

Best Delta 8 Gummies of 2025: Area 52 Named #1 Edible by Oregon Observer

While competitors push high-THC options, Area 52’s Delta 8 Gummies lead with a balanced, clear-headed experience—now joined by UFO MAX and UFO in the top 3
While competitors push high-THC options, Area 52’s Delta 8 Gummies lead with a balanced, clear-headed experience—now joined by UFO MAX and UFO in the top 3

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsCannabinoids